Artivion | CRY - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.6B 330M 2026-06
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Inogen USD 43.77M 510K 2024-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
J&J USD 6.42B 381M 2026-06
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Pfizer USD 3.41B 496M 2026-06
ResMed USD 290.65M 10.86M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Trinity Biotech USD 5.78M 405K 2025-12